CannaPharmaRX, Inc.
CPMD
$0.00
$0.002.70%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -78.89% | 183.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -78.89% | 183.51% | |||
| Cost of Revenue | -12.16% | 28.59% | |||
| Gross Profit | -87.41% | 29.17% | |||
| SG&A Expenses | -86.10% | 201.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.18% | 56.57% | |||
| Operating Income | 4.49% | -19.12% | |||
| Income Before Tax | -410.87% | -4.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -410.87% | -4.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -410.87% | -4.55% | |||
| EBIT | 4.49% | -19.12% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -418.18% | -4.76% | |||
| Normalized Basic EPS | -107.14% | -7.69% | |||
| EPS Diluted | -418.18% | -4.76% | |||
| Normalized Diluted EPS | -107.14% | -7.69% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||